Recruitment

Recruitment Status
Completed

Inclusion Criteria

Adult over 18
Eligible for PET-CT
Untreated diffuse large B-cell lymphoma
...
Adult over 18
Eligible for PET-CT
Untreated diffuse large B-cell lymphoma
The subject must be covered by a social security system
Untreated stage B or C chronic lymphocytic leukemia
Signed written informed consent

Exclusion Criteria

pregnant women
patients with creatinine clearance < 30 ml/mn
Weight over 120 kg
...
pregnant women
patients with creatinine clearance < 30 ml/mn
Weight over 120 kg
active infectious disease
Age under 18
Patients concurrently included in an investigational trial
immune hemolytic anemia
corticosteroid therapy

Summary

Conditions
Untreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma Patients
Type
Interventional
Phase
Phase 1
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Diagnostic

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Inclusion Criteria

Adult over 18
Eligible for PET-CT
Untreated diffuse large B-cell lymphoma
...
Adult over 18
Eligible for PET-CT
Untreated diffuse large B-cell lymphoma
The subject must be covered by a social security system
Untreated stage B or C chronic lymphocytic leukemia
Signed written informed consent

Exclusion Criteria

pregnant women
patients with creatinine clearance < 30 ml/mn
Weight over 120 kg
...
pregnant women
patients with creatinine clearance < 30 ml/mn
Weight over 120 kg
active infectious disease
Age under 18
Patients concurrently included in an investigational trial
immune hemolytic anemia
corticosteroid therapy

Tracking Information

NCT #
NCT02128945
Collaborators
CNRS, UMR ISTCT 6301, LDM-TEP Groupe, GIP Cyceron, Caen, France
Investigators
  • Principal Investigator: Sylvain P CHANTEPIE, MD University Hospital, Caen
  • Sylvain P CHANTEPIE, MD University Hospital, Caen